Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06683105

A Pilot Randomized Trial Investigating the MyIBDDiet App to Improve Self-management of an Anti-inflammatory Diet for Individuals With Inflammatory Bowel Disease

Led by University of Alberta · Updated on 2026-05-07

40

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the MyIBDDiet app designed to help patients with inflammatory bowel disease (IBD) learn about healthy eating. This study aims to determine if the app is easy to use and more effective than standard doctor-provided diet information. IBD includes Crohn's disease and ulcerative colitis, conditions that cause inflammation in the gastrointestinal tract, and diet plays a role in managing this disease by influencing the intestinal microbiome. The study randomly assigns participants into two groups: one group uses the MyIBDDiet app for 60 days, while the other group does not use the app for the first 30 days and then uses it for the following 30 days. The app allows users to track their food intake, including preparation methods and food processing, and provides immediate feedback on food choices. It also features symptom tracking and educational resources such as videos and visual tools to support healthy eating based on an anti-inflammatory diet. Participants will be involved for up to 60 days, during which they will use the app as assigned and complete surveys to assess the app's usability and acceptability. Researchers will measure the app's impact on diet quality and quality of life. The study monitors participant adherence and collects data through surveys, food tracking, and symptom logs to understand the app's role in supporting diet self-management for people with IBD.

CONDITIONS

Brief Title

Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years or older
  • Able to provide informed consent
  • Established diagnosis of inflammatory bowel disease confirmed by a treating physician
  • Not currently experiencing an acute flare
  • Not pregnant
  • Willing and able to follow all study procedures
Not Eligible

You will not qualify if you...

  • Short bowel syndrome
  • High ostomy output
  • Intestinal strictures
  • Pregnant or breastfeeding
  • Malnutrition as assessed by the Canadian Nutrition Screening Tool
  • Conditions requiring dietary restrictions such as celiac disease, kidney disease, diabetes, or eosinophilic esophagitis
  • Conditions requiring a low fiber diet like irritable bowel syndrome or gastroparesis
  • Currently on a therapeutic diet
  • Already following a diet or using a diet tool for IBD such as Mediterranean or anti-inflammatory diet
  • Active malignancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 30 to 60 days depending on study arm

Participants use the MyIBDDiet app to self-manage an anti-inflammatory diet for inflammatory bowel disease.

1 to 2 visits depending on arm assignment

Trial Site Locations

Total: 1 location

1

Zeidler Ledcor Centre, University of Alberta

Edmonton, Alberta, Canada, T6G 2X8

Actively Recruiting

Loading map...

Research Team

K

Karen Wong, MD, FRCPC

R

Ravneet Kaur, M.Sc.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Similar Trials

A Phase 1, First-In-Human Study to Evaluate the Safety, Tole...

Inflammatory Bowel Disease (IBD)

Actively Recruiting

1 location

A Phase 2, Multi-Center, Platform Study to Evaluate the Safe...

Inflammatory Bowel Disease (IBD)

Actively Recruiting

66 locations

Post-Marketing Surveillance of Vedolizumab Subcutaneous Inje...

Ulcerative Colitis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts.

John Gubatan, Chiraag V Kulkarni, Sarah Melissa Talamantes...

https://pubmed.ncbi.nlm.nih.gov/36771288

Identification and Evaluation of Mobile Applications for Self-Management of Diet and Lifestyle for Patients with Inflammatory Bowel Disease.

Stephanie L Gold, Brandon A Chiew, Vidya Rajagopalan...

https://pubmed.ncbi.nlm.nih.gov/37811532